| Literature DB >> 32112245 |
A Caycedo-Marulanda1,2,3, C P Verschoor4,5.
Abstract
BACKGROUND: The most important advancement in the surgical management of rectal cancer has been the introduction of total mesorectal excision (TME). Technical limitations to approaching mid and distal lesions remain. The recently described transanal TME makes it possible to minimize some of the difficulties by improving access. Anastomotic leak is a persistent concern after colorectal surgery no matter what technique is used. The objective of this study was to explore the impact of experience on the incidence of anastomotic leak after transanal TME. Secondary endpoints were local recurrence and margin status.Entities:
Keywords: Anastomotic leak; Learning curve; Rectal cancer; Single team; Transanal total mesorectal excision
Mesh:
Year: 2020 PMID: 32112245 PMCID: PMC7082408 DOI: 10.1007/s10151-020-02160-6
Source DB: PubMed Journal: Tech Coloproctol ISSN: 1123-6337 Impact factor: 3.781
Summary of patient characteristics
| Mean ± SD (min/max) | ||
|---|---|---|
| Age, years | 100 | 64 ± 10.8 (39.6/85) |
| Body-mass index | 100 | 27.6 ± 6.5 (16.8/50.4) |
| Tumour height | 100 | 6.17 ± 2.57 (0/13) |
| Operation duration | 100 | 5.09 ± 1.19 (0.25/8.02) |
NA missing data, ND not determined, SD standard deviation, min/max minimum/maximum, N sample size
Summary of recorded outcomes
| Value | |
|---|---|
| Anastomotic leaka | |
| No | 94 |
| Yes | 6 |
| Quality (surgical specimen) | |
| Complete | 83 |
| Near complete | 17 |
| Margins | |
| Circumferential | |
| Negative | 97 |
| Positive | 3 |
| Distal | |
| Negative | 100 |
| Complications | |
| Postoperative | |
| No | 66 |
| Yes | 34 |
| Intraoperative | |
| No | 98 |
| Yes | 2 |
| Readmission | |
| No | 89 |
| Yes | 11 |
| Conversion | |
| No | 100 |
| Local reoccurrence | |
| No | 98 |
| Yes | 2 |
a‘No’ anastomotic leak includes those patients in which no anastomosis was performed (n = 15). These individuals were removed prior to regression and CUSUM analyses
Associations between participant characteristics and the outcomes anastomotic leak and length of stay
| Variable | Level | Anastomotic leak (OR [95% CI], | Length of stay (beta [95% CI], | ||
|---|---|---|---|---|---|
| Univariate model | Multivariable model | Univariate model | Multivariable model | ||
| Age, years | - | 1.01 [0.93–1.09], 0.887 | 1.03 [0.94–1.12], 0.551 | 0.06 [− 0.02 to 0.13], 0.134 | 0.01 [− 0.07 to 0.09], 0.797 |
| Sex | Female | Ref | Ref | Ref | Ref |
| Male | 0.46 [0.08–2.65], 0.366 | 0.4 [0.07–2.34], 0.288 | |||
| Body-mass index, kg/m2 | – | 1.02 [0.89–1.15], 0.725 | 1.02 [0.88–1.15], 0.777 | 0.02 [− 0.11 to 0.15], 0.801 | 0.02 [− 0.11 to 0.14], 0.806 |
| Tumour height, cm | – | 1.09 [0.77–1.57], 0.621 | 1.12 [0.78–1.63], 0.546 | -0.29 [− 0.62 to 0.03], 0.075 | − |
| Neoadjuvant (chemotherapy) | No | Ref | Ref | Ref | Ref |
| Yes | 0.52 [0.09–2.97], 0.441 | 0.48 [0.07–2.98], 0.42 | 0.75 [− 0.98 to 2.48], 0.393 | 0.51 [− 1.15 to 2.18], 0.542 | |
| Neoadjuvant (radiation) | No | Ref | Ref | Ref | Ref |
| Yes | 0.44 [0.08–2.5], 0.331 | 0.42 [0.06–2.61], 0.333 | 0.51 [− 1.28 to 2.3], 0.572 | 0.03 [− 1.7 to 1.76], 0.97 | |
| Anastomosis type | Circular stapler | Ref | Ref | Ref | Ref |
| Hand sewn | NA | NA | 0.68 [− 1.71 to 3.07], 0.573 | − 0.19 [− 2.85 to 2.47], 0.89 | |
| None | NA | NA | 0.55 [− 1.84 to 2.94], 0.65 | − 0.9 [− 3.43 to 1.63], 0.482 |
Associations with anastomotic leak were estimated by logistic regression, and the odds ratio (OR), 95% confidence interval (CI), and p value were presented. Associations with length of stay were estimated by linear regression, and the regression coefficient (beta), 95% CI, and p value are presented. Multivariable models were adjusted for sex, body mass index, and tumor height. Significant (p < 0.05) associations are in bold
Ref reference level, NA not enough events were available to reliably calculate confidence intervals
Fig. 1Cumulative sum (CUSUM) analysis to detect improvement in the occurrence of anastomotic leak. Baseline risk was set to 7.8% and the threshold was set to detect a 50% improvement in the outcome rate. For this analysis, the threshold was crossed at trial number 50
Representation of the variables of a high-quality TME after taTME as reported by different authors
| Complete/near complete (%) | CRM (%) | DRM (%) | |
|---|---|---|---|
| Koedam et al. 2018 [ | 99 | 1.40 | 0 |
| Lee et al. 2018 [ | 99 | 2 | 1 |
| Lacy et al. [ | 97.30 | 8.10 | 3.20 |
| Caycedo-Marulanda et al. 2020 (this article) | 100 | 3 | 0 |
CRM circumferential radial margin, DRM distal radial margin